SEC Form 4/A · accession 0001064901-18-000002
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Christina Kay
Officer — Executive Vice President · Director
Period of report
Dec 19, 2018
Accepted (ET)
Dec 19, 2018 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016504
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 19, 2018 | A | 50,000 | $0.14 | A | 1,423,467 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F150,000 common stock shares acquired upon exercise of stock option grant dated January 23, 2009.
Remarks
This amendment is correcting the number of shares beneficially owned by the reporting person, Christina Kay.